Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings)
Portfolio Pulse from Benzinga Insights
Exact Sciences (NASDAQ:EXAS) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have adjusted their price targets, with the average now at $79.86, down from $81.33. The company's financial metrics show strong revenue growth but challenges in ROE and ROA.
October 29, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exact Sciences has received mostly bullish analyst ratings, with recent price target adjustments reflecting a slightly lower average. The company's financial performance shows strong revenue growth but challenges in ROE and ROA.
The majority of analysts have a bullish outlook on Exact Sciences, with recent price target adjustments indicating a slight decrease in expectations. The company's strong revenue growth is a positive indicator, but challenges in ROE and ROA may concern investors. Overall, the sentiment is positive, suggesting a likely short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100